Wrap up: Elanco receives FDA approval for Zenrelia, and other veterinary news

nenetus/stock.adobe.com

Good morning dvm360 readers! dvm360 is excited to announce that we have officially launched Fetch On-Demand for Fetch Kansas City 2024! Fetch On-Demand brings the best sessions, speakers, and CE opportunities straight to you, so you can learn when, where, and how it fits into your busy life. Whether you’re catching up between appointments, learning from the comfort of home, or squeezing in a quick session over coffee, Fetch On-Demand gives you the flexibility you need to earn CE credits your way. You can learn more and get Fetch On-Demand here today!

As you begin to enjoy Fetch On-Demand, here is what was popular this week on dvm360.com:

• Elanco announced this week that its product Zenrelia has received approval from the FDA. Zenrelia is a once a day orally, with or without food tablet to control pruritus associated with allergic dermatitis as well as atopic dermatitis in canine patients at least 1 year old.
• During an interview with dvm360 at Fetch Kansas City, Rachel Allbaugh, DVM, MS, DACVO, discussed multiple advancements now available for treating and managing squamous cell carcinoma.
• Wedgewood disclosed this week that it will be adding molnupiravir, which was first developed to treat human viral infections, to its formulary due to recent researcher demonstrating its promise for treating feline infectious peritonitis.
• On this week’s episode of The Vet Blast Podcast, host Adam Christman, DVM, MBA, welcomed Joya Griffin, DVM, DACVD, to discuss feline dermatology conditions, effective treatment options, and how general practitioners can communicate strategies better to clients.
• San Diego Zoo Wildlife Alliance in San Diego, California became the first place in the world to perform a cesarean section on a North American porcupine after one of their porcupines, Maizey, experienced complications during labor.
• And more!